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Assembly and budding of inﬂuenza virus proceeds in the viral budozone, a domain in the plasma membrane with characteristics
of cholesterol/sphingolipid-rich membrane rafts. The viral transmembrane glycoproteins hemagglutinin (HA) and neuraminidase
(NA) are intrinsically targeted to these domains, while M2 is seemingly targeted to the edge of the budozone. Virus assembly is
orchestrated by the matrix protein M1, binding to all viral components and the membrane. Budding progresses by protein- and
lipid-mediatedmembranebendingandparticlescissionprobablymediatedbyM2.Here,wesummarizetheexperimentalevidence
for this model with emphasis on the raft-targeting features of HA, NA, and M2 and review the functional importance of raft
domains for viral protein transport, assembly and budding, environmental stability, and membrane fusion.
1.Introduction
1.1. Inﬂuenza Viruses: Molecular Composition. Inﬂuenza
virus particles are heterogeneous in shape, either spherical
(with a diameter of roughly 100nm) or ﬁlamentous (with
a length of several micrometers). The particles contain the
viral genome, which is segmented into eight entities termed
viral ribonucleoprotein particles (vRNPs), each composed
of a segment of viral RNA complexed to the nucleoprotein
(NP) and the subunits of the viral RNA polymerase (PA,
PB1, and PB2). The vRNPs are encased by a protein layer
consistingofthematrixproteinM1,whichalsolinestheviral
envelope from beneath and is supposed to bind to all other
viralconstituents.Theviralenvelope isalipidbilayerderived
from the apical plasma membrane of the infected cell. There
are three transmembraneous viral proteins embedded in
the envelope: the glycoproteins hemagglutinin (HA) and
neuraminidase (NA), which protrude at the viral surface
as “spikes,” and—in minor quantities—the proton channel
protein M2. Here, we will focus on the buildup of the viral
envelope and the proteins involved (HA, NA, M2, M1),
which are depicted in Figure 1.
HA (blue in Figure 1)i sat y p eIt r a n s m e m b r a n ep r o t e i n
with an N-terminal signal peptide (white in Figure 1(a)),
which is cleaved oﬀ after cotranslational sequestration of
the nascent polypeptide chain into the endoplasmic reticu-
lum (ER), a large ectodomain (positioned in the ER lumen
and towards the extracellular milieu when located at the
plasma membrane), a single transmembrane region (TMR)
of approximately 27 amino acid residues located near the
C-terminus of the protein, and a short cytoplasmic tail
(approximately 11 residues).
HA assembles into a homotrimer in the ER and is trans-
ported via the secretory pathway to the plasma membrane,
more speciﬁcally the apical plasma membrane in polarized
(e.g., epithelial) cells, where virus assembly and budding
take place [2]. In the ER and Golgi, HA is glycosylated
in the ectodomain, and typically three saturated fatty acid
chainsarecovalentlyattachedtoC-terminalcysteineresidues
(S-acylation). The ﬁrst cysteine residue, at the border
betweenTMRandcytoplasmictail,ismodiﬁedwithstearate,
while the other two cysteines in the cytoplasmic tail carry
palmitates [3, 4].
The large ectodomain is processed into two subunits
(HA1 and HA2) by a protease provided by the host organism;
they remain linked by a disulﬁde bridge [5]. This proteolytic
maturation is needed to enable membrane fusion,w h i c hi s
exertedbyHAduringvirusentry:ahydrophobicparttermed
“fusion peptide” (cyan in Figure 1(a)) becomes exposed
at the N-terminus of HA2 after cleavage and is inserted2 Advances in Virology
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Figure 1:Themembrane-associatedproteinsofinﬂuenzavirusand
their raft association. (a) Primary amino acid sequence of hemag-
glutinin (HA, processed into HA1 and HA2, blue), neuraminidase
(NA, green), M2 (purple), and M1 (red, with amphiphilic helix in
black). Transmembrane regions (TMR) in gray, S-acylations in HA
and M2 indicated by zigzag line, signal peptide of HA in white,
and fusion peptide in HA in cyan. (b) Topology of HA, NA, M2,
and M1 in the membrane, raft localization indicated. Raft-targeting
features: (1) hydrophobic amino acids in the outer part of the
HA-TMR; (2) S-acylation of HA; (3) outer part of the NA-TMR;
(4) S-acylation and cholesterol binding of the amphiphilic helix of
M2. M1 according to the structure model of Shishkov et al. [1],
membrane-interactive regions in red. Only one monomer of the
trimeric HA and the tetrameric NA and M2 is shown for clarity.
into the host endosomal membrane upon activation of HA
(conformational change of the ectodomain by low pH).
Apart from membrane fusion, HA is also responsible for
receptor recognition: a binding pocket in HA1 recognizes
sialic acid moieties in glycoproteins and glycolipids on the
host cell surface [6].
NA (green in Figure 1) is a type II transmembrane
protein, which assembles into a homotetramer. The ﬁrst
ﬁve residues from the N-terminus form the cytoplasmic
tail, followed by a transmembrane anchor encompassing
approximately 30 residues and the glycosylated ectodomain.
NA is processed along the same intracellular route as HA
(ER-Golgi-apical plasma membrane). The main function of
the protein is cleavage of terminal sialic acid moieties from
glycans in the mucus of the host’s respiratory tract and on
the viral surface, thus helping in release of newly formed
viral particles from the host cell. NA is the target of the
anti-inﬂuenza drug oseltamivir and other neuraminidase
inhibitors [7].
M2, the third viral transmembrane protein (purple in
Figure 1), is also tetrameric and forms a proton channel
activated by acidic pH, the action of which is important
for genome unpacking during virus entry and can be
inhibited—at least in Inﬂuenza A virus strains—by the drug
amantadine. In each monomer, the ﬁrst 24 amino acids form
the ectodomain, which is not glycosylated, the following 19
residues are the transmembrane region, and the remaining
54 residues build up the cytoplasmic tail. The sequence
immediately following the TMR shapes a membrane-parallel
amphiphilichelix,anα-helixwithahydrophobicface(which
partially protrudes into the membrane), and a hydrophilic
face (which points to the cytosol). A cysteine residue in
this part of the protein is S-acylated. Similarly to HA and
NA, M2 is transported along the secretory pathway to the
apical plasma membrane, but the apical targeting signal in
M2 has not been identiﬁed. Contrary to the other viral
transmembrane proteins, however, M2 is largely excluded
from virus particles [8].
The matrix protein M1 (red in Figure 1) binds to
membranes, but does not have a transmembrane span [9–
11]. M1 is most likely attached to membranes by extended
regions of the protein or by the cooperative action of
several binding sites [12–16]. Concomitantly, a large portion
of the protein was found to be membrane-associated by
mass-spectrometry-based structural reconstruction [1]. M1
is central for virus morphogenesis as it is supposed to bind
to all other viral components including the vRNPs and the
membrane. However, M1 is not intrinsically targeted to
the assembly site, the apical plasma membrane, but rather
localizestothenucleus,internalmembranes,andthecytosol.
Plasma membrane targeting of M1 is therefore in all likeli-
hood mediated by at least one of the viral transmembrane
proteins (HA, NA, and M2). The interaction of M1 with the
cytoplasmic tails of HA (11 residues) and NA (5 residues)
has only been demonstrated indirectly, for instance, by
altered detergent solubility [17, 18] or increased membrane
association [19] of M1 in the presence of HA/NA, an eﬀect
not seen in all studies [15]. In contrast, the interaction
between M1 and the cytoplasmic tail of M2 (54 residues)
is well documented, most conclusively by coimmunopre-
cipitation [20, 21]. M1 has the capacity to oligomerize
[16], which is supposed to cluster the viral components
together at the site of virus budding to organize the assembly
process.
1.2. Biochemical and Biophysical Properties of Membrane
Rafts. Contrary to the classical view of the plasma mem-
braneasahomogenouslipidmixture,thereisnowconclusive
evidence indicating the presence of specialized lipid domainsAdvances in Virology 3
with distinct biochemical and biophysical properties. These
membrane rafts are dynamic assemblies of cholesterol, sphin-
golipids, and phospholipids containing saturated fatty acids.
Sphingolipids are exclusively present in the external leaﬂet
of the plasma membrane, whereas the composition of inner
leaﬂet rafts is not known, but it has been suggested that
cholesterol plus phospholipids with saturated acyl chains is
enriched [22, 23].
Membrane rafts have been characterized extensively in
model membrane systems. In the cholesterol/sphingolipid-
rich phase, the (mostly saturated) fatty acid chains of the
membrane lipids are densely packed and restricted in mobil-
ity, but still able to diﬀuse and rotate, and form a “liquid-
ordered” (Lo) phase segregated from the “liquid-disordered”
(Ld), more ﬂuid membrane phase. Upon phase separation
of Lo and Ld domains, there is a hydrophobic mismatch
and a height diﬀerence between the two membrane phases,
leading to the formation of a “line tension” at their interface.
This is conceptionally comparable to surface tension in a
three-dimensional system, which—for instance—leads to
the formation of a spherical drop of water on an oily surface
to minimize the contact area with the repellent surface.
Accordingly, line tension leads to the formation of a curved
raft phase due to the propensity of the system to minimize its
free energy [24].
However, no large-scale, long-lasting phase separation
is observed in the membranes of undisturbed cells—yet,
highly dynamic (millisecond range) and very small (10–
200nm) heterogeneous membrane organization dependent
onthepresenceofcholesterolhasbeenobservedinaplethora
of investigations using biophysical methodology of high
temporal and spatial resolution [25].
Raft domains are best described for the plasma mem-
brane, although cholesterol/sphingolipid-rich domains are
likely to build up already in the Golgi. There are raft-
targeting features in proteins for their association with rafts,
most decisively glycosyl-phosphatidylinositol (GPI) anchors
and S-acylation of cysteine residues [26]. Under certain
conditions, for instance, upon ligand binding and receptor
oligomerization, the highly dynamic “resting state” rafts can
be coalesced and stabilized to fulﬁll a biological function
[25, 27]. One example for functionalization of raft domains
aresignaltransductionprocesses,forexample,theformation
oftheimmunologicalsynapseintheactivationofTcells[28].
The assembly and budding of some viruses such as inﬂuenza
virus is also coupled to the formation of functionalized
raft domains, here termed “budozone.” In this context, rafts
provide a platform to concentrate the viral components and
to facilitate their interactions, while cellular proteins are
excluded [24, 25].
2.Associationof Inﬂuenza VirusProteins
with Raftsand Methods to AnalyzeThem
Inﬂuenzavirusassemblyandbuddingislinkedto(coalesced)
membrane rafts in the apical plasma membrane. Generally,
the spike glycoproteins HA and NA are assumed to be
raft-associated, while M2 is believed to be intrinsically
excluded from rafts. The peripheral membrane protein M1 is
considered not to have membrane subdomain speciﬁcity. In
the next paragraphs, we describe the experimental evidence
that had led to this model.
2.1. Hemagglutinin Is Present in Detergent-Resistant Mem-
branes. Historically, the raft hypothesis was introduced by
the observation that some parts of biological membranes
(enriched in cholesterol and sphingolipids) resist solubiliza-
tion by nonionic detergents such as Triton X-100 on ice and
ﬂoat to a low buoyant density upon density gradient cen-
trifugation. These “detergent-resistant membranes” (DRMs)
have been considered to be the biochemical correlate for
rafts. They have been found to contain proteins, which were
hence termed DRM-associated and regarded as raft proteins.
In addition, association with DRMs should be sensitive
to cholesterol extraction and inhibitors of sphingolipid
synthesis [26, 27].
The hemagglutinin (HA) of inﬂuenza virus was one of
the ﬁrst proteins described as a component of DRMs [29]
and has since been judged as paradigm for a raft-associated
transmembrane protein.
The detergent extraction method was used in combi-
nation with mutagenesis to identify molecular signals in
HA for raft localization. Alanine scanning of the whole
transmembrane region (an exchange of three consecutive
amino acids at a time by alanines) showed that hydrophobic
residues located at the outer leaﬂet of the membrane bilayer
are responsible for resistance against detergent extraction
[29, 30], see label 1 in Figure 1(b). In addition, S-acylation
at cytoplasmic and transmembrane cysteine residues (label
2) are required for partitioning of HA into DRMs [30].
From detergent-extraction experiments, it was concluded
that palmitate bound to the cytoplasmic cysteines is more
important for raft association than the stearate attached to
the transmembrane cysteine [31, 32].
Presently,onecanonlyspeculateonthemolecularmech-
anismbywhichtheraft-targetingsignalscauseincorporation
of HA into rafts. In principle, α-helical transmembrane
regions with their protruding amino acid side chains should
rather disrupt the tight packing of lipids in a raft domain
as they do not readily accommodate the rigid, bulky sterol
ring of cholesterol. However, direct binding of cholesterol
to the protein could lead to raft targeting. In motifs
such as the “cholesterol recognition/interaction amino acid
consensus” (CRAC, [33]) or the “cholesterol consensus
motif” (CCM, [31]), a large aliphatic residue (valine or
isoleucine), a tyrosine or phenylalanine residue, and a basic
amino acid (arginine or lysine) coordinate the cholesterol
moiety if positioned accordingly. It is conceivable that the
raft-targeting residues in the HA-TMR (valine-isoleucine-
leucine/VIL), two of which (IL) are strictly conserved across
all HA subtypes, form part of a cholesterol interaction
pocket. However, since atomic structural information of
the HA-TMR is still lacking, it is unclear whether the
amino acids in question are ideally positioned. Binding
to cholesterol might target HA to preexisting rafts as
predicted in the “lipid shell” model for raft association4 Advances in Virology
of proteins [32]. Alternatively, it has recently been shown
that a peptide representing the transmembrane region of
HA induces highly ordered domains in model membranes,
but only if the conserved leucine residue is present [34].
Assuming a similar mode of action of the TMR in cellular
membranes,thiswouldimplythatHAinducestheformation
of its own raft domains. Furthermore, the substitution of
hydrophobic TMR residues by less hydrophobic alanines
might shorten the length of the transmembrane span.
A long TMR might be required for partitioning of HA
into rafts, which are thicker compared to other mem-
brane regions due to stretching of the lipids’ fatty acid
tails.
The presence of the second raft-targeting feature in HA,
S-acylation, seems to be a common principle in many raft
proteins [35]. It could be imagined that ﬂexible acyl chains,
especially if attached to the beginning of the transmembrane
region, ﬁll the voids in the irregular and rough surface of
the transmembrane domain and thus “lubricate” the region
for subsequent interactions with cholesterol. In addition,
fatty acids attached to the cytoplasmic tail of HA might
attract cholesterol, as suggested in the crystal structure of
the β-adrenergic receptor, in which cholesterol is visible
in the vicinity of covalently bound palmitate. However,
it should be noted that S-acylation perse,i r r e s p e c t i v eo f
whether palmitate or stearate is attached, is not suﬃcient to
cause raft localization of viral transmembrane proteins [36].
An example is the HEF glycoprotein of inﬂuenza C virus,
which does not associate with DRMs, but is stearoylated at
a transmembrane cysteine [3, 12].
It has been questioned repeatedly whether association
withDRMsreﬂectsraftassociationofaproteininlivingcells.
Components might be enriched in DRMs simply because
they possess common biophysical properties. Furthermore,
partitioningofproteinsintodetergent-solubleand-insoluble
fractions is seldom absolute; sometimes, only very few
percent of a protein population are present in DRMs.
Extraction conditions are not standardized, and therefore
results obtained by using diﬀerent protocols can hardly
be compared [37]. Thus, more sophisticated methods have
subsequently been used to conﬁrm and characterize the raft
localization of HA.
2.2. Analysis of the Distribution of HA with High-Resolution
Methods. Fluorescence microscopy in living cells has failed
to reveal laterally segregated clusters of HA or other raft-
associated proteins and lipids, indicating that rafts in
undisturbed cells must be smaller than the resolution of
the light microscope (<200nm). However, when antibodies
against both HA and a glycolipid-anchored protein were
applied, HA was found to cocluster with the established
raft component. It was assumed that cross-linking of HA
trimers by antibodies stabilizes small raft structures, which
subsequently coalesce with other raft domains to form
large, visible patches [38]. However, this study could not
establish potential clustering of HA in unperturbed cells.
Since then, methods with a higher lateral resolution than the
conventional light microscope have been used.
Immunoelectron microscopy combined with rigorous
statistical analysis showed that in transfected cells HA
neither is randomly distributed in the plasma membrane
nor accumulates only in very small domains with the
size of a small, dynamic raft. Instead, clustering of HA
molecules on diﬀerent length scales from 20nm up to
900nm was found. In the course of virus infection, the
HA clusters were observed to increase in size, indicating
increasing coalescence of HA-containing domains. Since
the nanodomains contained the ganglioside GM1, they are
likely derived from rafts. However, only HA clusters at the
nanometer length scale, that is, with the size of uninduced
rafts, could be disintegrated by extraction of cholesterol [39,
40]. Fluorescence-photoactivation-localization microscopy
(FPALM),arecentlydevelopednanoscopicmethodwithvery
high spatial resolution (40nm), essentially conﬁrmed HA
clustering for unﬁxed, living cells [41].
Thus, HA somehow accumulates in microdomains of the
membrane or even induces their formation, which leads to
its separation from most cellular proteins. Since the area
of the HA cluster is large enough to cover the surface
of a spherical virus particle, these structures were termed
the viral preenvelope or the viral budozone to indicate
that they might be a precursor of budding virus particles
[39, 42]. The large size of the HA clusters suggests that
they are composed of several small rafts. In addition, the
HA clusters do not possess round (perimeter minimized),
but irregular domain boundaries with long and narrow
extensions. This suggests that not only partitioning of HA
into rafts, but also other mechanisms for formation of
membrane subdomains may be responsible for clustering of
HA [39, 43]. One candidate for such a function is cortical
actin, which generates a meshwork of microﬁlaments at the
inner leaﬂet of the plasma membrane that might transiently
entrap HA [44]. Furthermore, cortical actin might organize
andmaintaintheformationofrafts[45].Thiseﬀectmightbe
mediated by the lipid phosphatidylinositol-(4,5)-phosphate
(PtdIns(4,5)P2), a key regulator of assembly and disassembly
of microﬁlaments [46]. The actin cytoskeleton has also been
shown to be functionally linked to rafts in the context of
virus infection: the disruption of the actin meshwork leads
to a redistribution of HA and to reduced budding, most
relevantly in the case of ﬁlamentous virus particles, maybe
because their surface area is higher than in spherical particles
[38].
F¨ orster’s (or ﬂuorescence) resonance energy transfer
(FRET) is exceptionally well suited to demonstrate very close
association between two molecules, for example, if they
populate the same small raft domain, even for a very short
time period. FRET relies on the transfer of energy from
an excited donor ﬂuorophore, such as the cyan-ﬂuorescent
protein (CFP), to an acceptor ﬂuorophore, for example,
the yellow-ﬂuorescent protein (YFP), if they are in very
close vicinity to each other (<10nm). Association of two
proteins can be assessed in cells by fusing them to CFP and
YFP, respectively, and conducting FRET measurements. To
exclude that a FRET signal is due to random collision of
two molecules, as it may occur frequently if both diﬀuse
in the plane of a membrane, the FRET data obtained mustAdvances in Virology 5
be correlated with the expression level of the probes. If
the FRET eﬃciency increases with the concentration of the
FRET acceptor protein at the membrane, FRET is caused by
random collision. In contrast, if FRET is due to clustering of
the two proteins under study, the FRET eﬃciency is largely
independentoftheconcentrationoftheacceptorproteinand
s a t u r a t e de v e na tr e l a t i v e l yl o wF R E Ta c c e p t o rc o n c e n t r a -
tions [39, 40]. To evaluate the data, a hyperbolic function is
ﬁttedtothedata,whichyieldsa“dissociationconstant”KD as
a parameter to assess the associative properties of donor and
acceptor [43]. Inﬂuenza virus HA, fused at its cytoplasmic
tail to CFP [42], clusters with an established marker for
inner leaﬂet rafts, myristoylated and palmitoylated YFP
[43]. Furthermore, an artiﬁcial HA-derived FRET probe,
consisting of a signal peptide, a ﬂuorescent protein, and the
transmembrane as well as cytoplasmic domain of HA [44],
clusters with a glycolipid-anchored protein, an established
marker for rafts of the outer leaﬂet. In this construct,
tagging of the cytoplasmic tail was circumvented to avoid
interference with its role in lateral organization. For both HA
constructs, clustering was signiﬁcantly reduced when rafts
were disintegrated by cholesterol extraction and when the
two described raft-targeting signals of HA were removed.
Both signals had a similar eﬀect on raft-targeting of HA and
did not work synergistically with each other.
One disadvantage of the FRET technique is that neither
KD values nor FRET-eﬃciencies can be compared between
diﬀerent protein pairs, even if they are attached to the
same donor and acceptor ﬂuorophore. The FRET eﬃciency
depends on the distance between the donor and the acceptor
and their relative orientation, parameters which cannot be
measuredwithincells.Itisthusnotpossibletodeterminethe
percentage of molecules that interact with a raft marker or
quantitatively compare the raft association of diﬀerent viral
proteins.
2.3. Diﬀusional Mobility of HA at the Plasma Membrane. It
has been hypothesized that the embedding of a protein in
raftdomainsleadstoaslowerdiﬀusioncomparedtonon-raft
proteins, which diﬀu s ea ss i n g l ee n t i t i e s[ 47]. Accordingly,
ﬂuorescence recovery after photobleaching (FRAP), where
the speed of replenishment of a previously bleached spot
within the membrane is measured, was employed for HA.
More than 80% of all HA molecules proved to be mobile,
indicatingthattheHAclustersarenotstaticinthetimeframe
of FRAP experiments (several minutes). Wild-type HA
diﬀused somewhat slower compared to HA with deleted
raft-targeting signals, but its diﬀusion rate was elevated to
non-raft HA values after disruption of rafts by depletion
of cholesterol [48]. However, HA (with or without raft-
targeting signals) diﬀused much slower compared to the
marker of inner leaﬂet rafts indicating that they do not
diﬀuse together in a stable raft complex [42].
Yet, the diﬀusional mobility as measured by FRAP is
determined by the type of transmembrane anchorage rather
than raft localization: proteins anchored by lipid moieties
(prenylation, S-acylation) diﬀuse quicker than transmem-
braneproteinsregardlessofwhethertheyassociatewithrafts;
the raft protein HA shows similar diﬀusion behavior as the
non-raft protein G from vesicular stomatitis virus (VSV-G)
[49].
FRAPisonlysuitabletodeterminetheoverallmobilityof
HA over a large area of the plasma membrane (several μm2),
which contains both raft and non-raft domains. To dissect
the diﬀusional behavior of HA on the very small spatial
and temporal scale of (undisturbed) rafts, methodology of
very high resolution needs to be employed [50]. Indeed, the
nanoscopic method FPALM showed that HA is mobile when
observed at high spatial resolution (<200nm), that is, at
the dimension of the HA cluster. It was concluded that the
membrane enwrapping the HA cluster is not composed of
a solid phase and thus allows HA molecules to diﬀuse and
eventually leave the boundary of the cluster [41].
No studies have been done on the clustering behavior of
HA in its natural habitat, the apical membrane of polarized
cells, which is particularly rich in raft lipids and possibly
mostly raft-like; that is, the raft domain might be the
dominant, percolating phase [51]. In other membranes, rafts
are believed to be minor domains which ﬂoat like a ship in
a sea of non-raft lipids, a property to which the name “raft”
refers. It might well be that the diﬀerent properties of apical
membranes might aﬀect clustering and diﬀusion of HA.
In summary, these results are consistent with a model of
dynamic partitioning of HA into and out of pre-existing raft
domains, which permits the protein to transiently populate
raft domains, as well as to undergo diﬀusion outside of rafts.
Alternatively, HA might transiently induce the formation
of rafts, which rapidly dissipate if no further stimulus is
delivered. Recent real time studies on the biogenesis of
individual human immunodeﬁciency virus (HIV) particles
have shown that ﬁve to ten minutes are required for particle
assembly and additional 20 minutes for budding and release
[52, 53]. Assuming that a similar time frame applies for
assembly and budding of inﬂuenza virus particles, it is
unclearhowsuchunstableHAclusterscansupportthewhole
assembly process. However, it is reasonable to assume that
in the context of virus infection, binding of HA to M1 and
the subsequent oligomerization of the latter might further
stabilize the HA clusters and serve as a nucleation site for the
recruitment of viral RNPs.
2.4. Model Membranes to Analyze Raft Localization of HA.
Raft association of HA has also been analyzed in vitro using
model membranes, which have the advantage that their
chemical composition can be accurately controlled. One
suitable system is giant unilamellar vesicles (GUVs), spher-
ically closed free-standing bilayers with a size in the range
of tens of micrometers, thus having a cell-like curvature.
When prepared from phospholipids, sphingomyelin (SM),
and cholesterol at a molar ratio of 1:1:1, the “canonical
raft mixture,” separation of the lipids into two phases occurs.
The phases can be visualized by ﬂuorescence microscopy
using ﬂuorescent lipid probes, which favor either the liquid-
disordered (Ld) or the liquid-ordered (Lo), raft-like phase.
Membrane proteins, chemically labeled with a ﬂuorophore,
can be reconstituted into GUVs which allows direct testing6 Advances in Virology
of the phase preference of a protein [54]. Surprisingly, HA,
either the authentic protein puriﬁed from virus particles or a
peptiderepresentingitstransmembraneregion,isexclusively
present in the liquid-disordered, non-raft domain [55].
However, only a few proteins considered as raft components
in living cells, for example, GPI-anchored proteins, associate
with the raft domains in GUVs.
Using swelling procedures, artiﬁcial membranes can also
be prepared from the plasma membrane of a cell that
expresses a ﬂuorescent construct of the protein of interest.
Similarly to GUVs, these giant plasma membrane vesicles
(GPMVs) show long-lasting, large-scale separation into raft
and non-raft phase upon cooling, but contain the lipid
and protein diversity of natural membranes. Using such
membranes, partitioning of HA (fused to a ﬂuorescent
protein) was more variable; that is, a minor, but signiﬁcant
amount was also present in the raft-like phase [55, 56].
The diﬀerences in raft localization of HA in cellular
membranes, GPMVs, and GUVs might be explained by
diﬀerences in the packaging order of their lipids. Using
ﬂuorescent lipid probes, it was shown that the raft phase
is most densely packed in GUVs, a property which might
prevent access especially of transmembrane proteins [55,
57]. In addition, GUVs and GPMVs lack cortical actin
which probably helps in organization and maintenance of
raft domains in cells. Furthermore, lipid asymmetry of the
bilayer,characteristicfortheplasmamembraneofcells,isnot
preserved in GUVs and GPMVs. Finally, in some procedures
to prepare HA or GPMVs, the reducing agent dithiothreitol
(DTT) is used, which is known to cleave oﬀ thioester-
bound fatty acids. In the mentioned studies, this might have
removed the raft-targeting feature and concomitantly have
led to non-raft localization of HA. An alternative procedure
for GPMV formation which avoids the usage of DTT showed
that many proteins predicted to be raft-localized in cells par-
titionintotheorderedphase[35].Thestudyalsoshowedthat
a large fraction of raft-associated transmembrane proteins
is palmitoylated and that this hydrophobic modiﬁcation is
required for raft partitioning. It will be interesting to see how
HA behaves in that artiﬁcial membrane system.
In principle, faithful reconstitution of viral proteins into
model membranes might be the ﬁrst step towards an in vitro
system for virus assembly and budding that would allow to
decipheralltherequiredcomponents,thatis,individualviral
proteins and lipids.
2.5. Raft Localization of Other Inﬂuenza Virus Membrane Pro-
teins. Much less is known about the raft localization of the
second glycoprotein of inﬂuenza virus, the neuraminidase
NA, which is also DRM-associated and apically transported.
The signals for apical transport and raft localization are
both situated in the transmembrane region of NA, but
overlap only partly. Raft targeting was mapped to the TMR
half situated in the outer membrane leaﬂet (label 3 in
Figure 1(b)), but the molecular cause for this has not been
determined [58, 59]. Immunoelectron microscopy showed
that NA localizes to the same microdomains as HA in virus-
infected cells [60]. No functional ﬂuorescent construct of
NA has been described so far that would allow to study
raft association in living cells similarly to the experiments
conducted with HA, for example, by FRET.
The matrix protein M1 does not contain a transmem-
brane domain and is anchored to cellular membranes by
a variety of interactions [14]. M1 expressed alone is not
associated with DRMs, but coexpression of HA and/or NA
increases detergent resistance of M1 [17, 18]. It was therefore
proposed that M1 is drawn to rafts of the plasma membrane
by interactions with the cytoplasmic tails of HA and NA, but
suchaninteractionhasnotbeendirectlydemonstratedsofar.
However, viruses lacking the cytoplasmic tails of HA and NA
were found to have severe assembly defects, show irregular
morphology, and are defective in vRNP packaging [61].
Those defects were much less pronounced when only one
cytoplasmic tail was missing indicating redundant functions
of both tails [62].
The second splice product of the M gene, the ion-
channel protein M2, is not associated with DRMs [18].
However, M2 possess two possible raft targeting features, S-
acylation [63]a n da na ﬃnity for the raft-lipid cholesterol
[64]. Several overlapping CRAC motifs, which are thought
to mediate the interaction with cholesterol, and the single
acylation site are both located within an amphiphilic helix
in the cytoplasmic tail of M2 (label 4 in Figure 1(b)).
It was therefore proposed that acylation and cholesterol
binding target the amphiphilic helix to the raft domain but
the relatively short transmembrane region of M2 prevents
complete immersion of the protein in the more ordered,
hence thicker raft domains. As a consequence, M2 was
hypothesized to localize to the edge of the viral budozone, to
be involved in raft coalescenceand to mediate pinching oﬀ of
virus particles from the plasma membrane by the induction
ofcurvaturethrough wedge-like insertion ofthe amphiphilic
helix into the membrane [64].
Testing possible raft localization of M2 with FRET
showed that the molecule (fused to a ﬂuorescent protein)
does not interact with the double-acylated marker for
inner leaﬂet rafts [65]. However, in GPMVs prepared in
the absence of DTT, M2 (partly) partitioned into the raft
domain, a property which was dependent on acylation, but
not on intact CRAC motifs. Thus, in principle, M2 can
interact with raft domains but an enrichment at the interface
between the liquid-ordered and -disordered phase was not
observed in this system [66].
Surprisingly, the results from FRET experiments point
to an interaction (or very close colocalization) of M2 with
HA [65]. The FRET signal between M2 and HA (fused to
ﬂuorescent proteins) depends on the raft-targeting signals
of HA and on an intact actin cytoskeleton, reinforcing the
notion that cortical actin is involved in the organization
of the viral budozone. How can it be reconciled that M2
clusters with raft-associated HA, but not with the double-
acylated raft marker? The raft marker, when expressed in the
absence of HA, is probably present in small, unstimulated
rafts, to which M2 has no access. HA organizes the larger
viral budozone, into which the raft marker can partition; M2
apparently interacts with this functionalized domain. Thus,
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theviralbudozone;thissignalmightbeidenticalorsimilarto
the(unidentiﬁed)signalforapicaltargetingoftheprotein.In
the course of virus infection, M2 shows increasing DRM and
cholesterol-rich membrane association [67]. This is most
likely mediated by the matrix protein M1, which bridges the
viral components in the budozone.
There are two reports describing that the nucleoprotein
NP, the major vRNP component, localizes to apical mem-
branes and associates with DRMs, even when expressed in
the absence of other viral proteins [68, 69]. This observation
implies that NP contains intrinsic signals for apical transport
and raft association, although the protein is hydrophilic and
is not modiﬁed by lipid moieties. However, others have not
seen polarized localization of NP in transfected cells [16].
3. Function of Rafts for Inﬂuenza
Virus Replication
It is assumed that rafts play a decisive role at several steps
duringvirusreplicationandarehencevitalforvirusviability.
These steps include intracellular transport of viral proteins
(most notably HA) to the assembly site, assembly and
budding of progeny virus particles at the plasma membrane,
environmental stability of the virus particles, and fusion of
viral and host cell endosomal membrane upon virus entry.
3.1. Intracellular Transport of HA. HA is transported to the
apical plasma membrane viathe secretory pathway. Deletion
of the raft-targeting sequence in the outer leaﬂet of its trans-
membrane region severely retards Golgi-localized processing
ofHA,suchasacquisitionofEndo-Hresistantcarbohydrates
and proteolytic cleavage. In contrast, trimerization of the
molecule in the ER was not aﬀected demonstrating that the
transport delay is localized to the Golgi apparatus (Engel,
de Vries, Herrmann, Veit, submitted). This is in line with
a recent model on the organization of vesicular transport
through the Golgi, which predicts that each cisterna of
this organelle contains two lipid phases, a “processing
domain” enriched in glycerophospholipids and an “export
domain” enriched in cholesterol and sphingolipids. Pro-
cessing enzymes, such as glycosyl transferases, are mostly
excluded from export domains and therefore remain trapped
in the Golgi, whereas transmembrane cargo proteins pref-
erentially partition into the export domain [70]. Thus,
decreasing the access to raft-like export domains should
decelerate transport of transmembrane proteins through the
Golgi. Since the second signal for targeting of HA to rafts of
the plasma membrane, S-acylation at cytoplasmic cysteines,
had no eﬀect on transport, the putative export domain
in the Golgi diﬀers from conventional rafts of the plasma
membrane.
Membrane rafts might also be involved in further
steps of HA transport. It was postulated early on that
cholesterol-sphingolipid clusters form vesicles in the trans-
Golgi network (TGN), which serve as carriers for these lipids
and entrapped proteins to the apical plasma membrane in
epithelial cells [71, 72]. This model suggests that association
with raft-like membranes is a prerequisite for apical trans-
portofHA.Indeed, HAacquiresdetergentresistanceatalate
stage during its transport to the cell surface, probably in the
TGN [73],andloweringcholesterollevelsblockstransportof
HA from the TGN to the cell surface [74]. However, several
mutations in the transmembrane region of HA have been
describedwhichblockassociationwithDRMs,butnotapical
transport [75]. The lipid content of plasma membrane rafts
could diﬀer from that of transport vesicles. This could be
determinedexperimentallybypuriﬁcationofHA-containing
transport vesicles and analysis of their lipidome [76]. In
short, there is evidence that raft domains are involved in
forward transport of raft-associated cargo proteins such
as HA through Golgi and TGN. This is accompanied by
an increasing cholesterol content along the secretory route
(ER<Golgi<plasma membrane, [77]).
3.2. Budding of Virus Particles. The two glycoproteins of
the virus, hemagglutinin (HA) and neuraminidase (NA),
accumulate in rafts of the plasma membrane. M1 is then
supposed to weakly bind to the cytoplasmic tails of HA and
NA. Oligomerization of M1 strengthens the weak interac-
tions with HA and NA and draws M1 to the viral budozone.
M2, which is abundantly expressed at the plasma membrane,
but largely excluded from virus particles, assumingly accu-
mulates at the edge of the budozone. Finally, interactions
between vRNPs and M1 initiate budding and release of virus
particles[69,78–81].Duringthatprocess,itmustbeensured
that most newly formed virus particles contain a complete
set of vRNPs. Since cryoelectron tomography has shown that
each virus particle contains a speciﬁc pattern of exactly eight,
individuallydiscerniblevRNPs,ahighlyselectivemechanism
of genome packaging is currently the favoured model [82].
Short nucleotide sequences identical in every RNA segment,
which are situated at the 5 -a n d3  -termini of each RNA,
form a terminal panhandle structure that is required for
packaging into RNPs, but the individual packaging signals
present in each vRNP still need to be identiﬁed [83, 84].
Budding is a membrane-remodeling process which
entails membrane bending (induction of curvature), that
leads to the formation of an Ω-shaped bud, followed by con-
strictionofthebud’sneck,and,ultimately,thedisconnection
of the particle (scission) owing to very close apposition and
fusion of the neck membranes [85]. During the whole bud-
ding process, apartof the(almost)planarplasmamembrane
is converted into a spherical (highly curved) vesicle. Since
the plasma membrane tends to stay ﬂat, this shape change
is an energetically unfavorable process and the required
energy must be provided by interaction with proteins [86].
Principally, there are two ways how proteins can induce cur-
vature in cellular membranes. Intrinsically curved proteins
o rp r o t e i no l i g o m e r sc a np r o v i d e“ s c a ﬀolding” that leads to
membrane bending; partially membrane-inserted proteins
or protein domains can act as a “wedge” by displacing mem-
brane lipids in only one bilayer leaﬂet [86–88]. The lipids
themselves can intrinsically favor curvature if they are “cone-
shaped” (if they exhibit a diﬀerence in the cross-section area
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In addition, since a small spherical virus contains roughly
10% more lipid molecules in the outer bilayer compared to
the inner bilayer [86], enrichment of outer leaﬂet lipids (or
partial depletion of inner leaﬂet lipids) at the budding site
will aid in membrane deformation. Finally, formation of raft
domains could also aid in the process of budding. In that
case, the hydrophobic mismatch and the height diﬀerence
between the domains leads to a “line tension” at the
domain interface. To minimize the free energy of the system,
curvature is induced in the bilayer of the budozone, which
may initiate or support protein-based budding [89, 90].
In contrast to many other enveloped viruses, it is still
not unambiguously deﬁned which of the inﬂuenza virus
proteins provide the energy for membrane deformation. To
experimentally determine the driving force for budding, that
is, the “minimal set” of required viral proteins, the proteins
in question are expressed in cells and the shedding of “virus-
like particles” (VLPs)—vesicles containing the expressed
viral proteins and having the same density as actual virus
particles—is detected biochemically. At ﬁrst, M1 was found
to be suﬃcient for VLP production [91, 92], consistent with
a budding model based on scaﬀold formation by the matrix
protein. This might, however, have been an artifact of the
expression system; in chemically transfected cells, HA and
NA [93–95] rather than M1 were found to be suﬃcient for
VLP formation. Remarkably, it was found that M1 artiﬁcially
taggedwithlipidanchorsistargetedtotheplasmamembrane
and is then suﬃcient for VLP formation [96]. In the context
of virus infection, M1 can fulﬁll this function by being
transported to the plasma membrane by the other viral
membrane proteins (see above). Of these, HA and NA are
also capable of triggering VLP formation on their own, albeit
with increased eﬃciency if M1 is coexpressed [93]. When
HA and NA cytoplasmic tail mutants were included in the
VLPs, M1 failed to be eﬃciently incorporated into VLPs,
consistent with a model in which the glycoproteins control
virus budding by sorting to lipid raft microdomains and
recruiting the internal viral core components. It has to be
kept in mind, however, that VLP formation is prone to
artifacts as cells tend to continuously shed vesicles that might
unspeciﬁcally incorporate the overexpressed viral protein
[97].
The role of rafts for virus budding has also been
analyzed in the context of virus infection. Removal of
the raft-targeting signal in the transmembrane region of
HA decreased virus production, and there was less HA
incorporated in the produced particles. This HA mutant was
randomly distributed over the plasma membrane, contrary
towild-typeHA.Thus,clusteringofHAinrafts,asdescribed
above for wild-type HA, ensures its inclusion in particles
and/or is required for eﬃcient budding [98].
Likewise, the interferon-induced cellular protein viperin
increases the lateral mobility of HA by decreasing its
raft association and severely inhibits the release of virus
particles [99]. Many of the virions on the surface of viperin-
expressing cells displayed a “daisy-chain” structure in which
two or more viral particles appeared to be linked by a
connecting membrane. Similar (or other) abnormal virus
structures have been observed for viruses with deletions of
the cytoplasmic tails of HA and NA [61]. Viruses containing
HA without the two palmitoylated cytoplasmic cysteines
incorporated reduced amounts of the internal components
NP and M1 and also revealed defects in virus release.
Surprisingly, exchange of the M1 protein by that of a
diﬀerent inﬂuenza virus strain restored assembly of viruses
with nonpalmitoylated HA [100]. This observation links
palmitoylationofHAtothematrixprotein.However,similar
experiments with H7-subtype HA did not reveal a defect
in virus budding, but in virus entry by membrane fusion
(see below, [101]). Nevertheless, the cumulative evidence
just described clearly indicates that HA (and especially its
S-acylated cytoplasmic tail) plays an important role in virus
budding.
The ultimate step in virus budding is the scission of the
virus particle from the plasma membrane. Recent evidence
indicates that this is mediated by the amphiphilic helix of
M2, probably acting as a “wedge.” Peptides representing the
helix induced the formation of vesicles from GUVs [67].
Mutation of ﬁve hydrophobic residues in the amphiphilic
helix of the M2-CT aﬀected virus shape and virus budding
[67, 102]. However, neither the CRAC motifs implied in
cholesterol binding nor acylation are absolutely essential for
the production of virus particles: there are virus strains in
which the acylation site or intact CRAC motifs are lacking,
and recombinant viruses in which the acylated cysteine
[103] or parts of the CRAC motifs [104] were replaced
grew similarly well as the corresponding wild-type virus,
and deletion of both the CRAC motif and the acylation
site simultaneously also did not aﬀect virus production, at
least in cell culture (Thaa, Wolﬀ, Herrmann, Veit, to be
published). However, attenuation of virus infectivity was
observed in mice both for virus with nonacylated [105]a n d
CRAC-disrupted [104]M 2 .
In addition, it is likely that cellular proteins contribute
to budding. The endosomal sorting complex required for
transport (ESCRT), parts of which are involved in budding
of other viruses such as HIV, seems to be dispensable for
inﬂuenza virus budding [93, 106]. There is however some
evidence that actin is involved especially in the formation
of ﬁlamentous virus particles [38, 107]. Polymerisation of
actin could provide a pushing force to extend the growing
bud. Additionally, the endocytic recycling GTPase Rab11
was recently identiﬁed as a budding cofactor [108]. It
was subsequently shown that Rab11 (and the underlying
vesicular transport pathway) is involved in cytoplasmic
transport of vRNPs to the plasma membrane [109]. It will
be interesting to decipher its exact mode of action as well as
to identify possible other cellular budding factors.
To summarize, eﬃcient budding of inﬂuenza virus
seems to come about by the combined action of scaﬀold-
based, wedge-mediated, and domain-induced processes (see
Figure 2). M1 oligomerization could provide a scaﬀold, the
amphiphilichelixofM2mightactasawedge,andbothwork
in concert with the HA-induced formation of a large-scale,
intrinsically bent raft domain. However, it is surprising
that mutations in several protein domains suggested to be
essential for virus budding, such as the cytoplasmic tails of
HA and NA and large parts of M2 including its amphiphilicAdvances in Virology 9
helix, sometimes have no or only a moderate eﬀect on virus
replication [61, 62, 103, 104, 110–113]. Thus, budding can
be considered to be a particularly robust process, relatively
insensitive to disturbing eﬀects or the failure of one of the
many functionalities. The precision of the assembly process,
that is, how faithfully all viral elements are included into
one particle, is not known. The overwhelming majority of
released particles (90–99%) are noninfectious, indicating
that not all viral elements have been incorporated in a
functionally active form. However, other causes for the
failure to initiate infection, such as successful interference
by a cellular factor, binding to an inappropriate receptor, or
defects in membrane fusion, certainly contribute to the high
proportion of non infectious virus particles. Furthermore,
highly puriﬁed virus particles contain various cellular
proteinsdemonstratingthattheywereincompletelyexcluded
from the budding site [114]. The probably high error rate
of virus budding distinguishes it from budding of cellular
transport vesicles, which otherwise follow similar principles
[115].
3.3. Stability of the Viral Envelope. It has been observed early
on that the inﬂuenza virus envelope contains detergent-
insoluble and ordered lipid assemblies [116]. Recently, a
detailed comparison of all the lipid species present in virus
particles and in the apical membrane of epithelial host
cells revealed that cholesterol and sphingolipids are enriched
in the viral membrane providing conclusive evidence that
viruses bud through raft domains (Mathias J. Gerl and
Kai Simons, personal communication). The question arises
whether the raft lipids in the envelope are just a nonfunc-
tional by-product of virus budding through rafts or whether
they serve a speciﬁc function during subsequent steps of the
v i r a ll i f ec y c l e .
A recent NMR study on the mobility of lipids in the viral
envelope suggests that the raft lipids might be important for
airborne transmission of viruses between individuals [117].
The lipids form both ordered (raft-like or solid) as well as
disordered phases, but their relative proportion is strongly
dependentonthetemperature.At4◦C,theenvelopeisalmost
entirely in the ordered phase, which, however, is only a
signiﬁcant, but minor fraction at 41◦C. The occurrence of
two phases, probably caused by diﬀerent lipid assemblies,
might explain why HA and NA spikes are not randomly
distributed in the viral envelope—rather, local clusters of NA
spikes, surrounded by the more abundant HA, are observed
by cryoelectron tomography [69, 118].
Thus, inclusion of raft lipids into the viral envelope
equips the particle with a versatile system that autonomously
regulates the rigidity of the membrane to ﬁt the respective
physiological needs. After discharge of a virus particle from
the lungs of an infected person, the virus is exposed to lower
temperatures.Thisleadstosolidiﬁcationoftheviralenvelope
to protect the viral genome against environmental damage.
In accordance with this, cold conditions favour transmission
of inﬂuenza virus explaining its predominant winter spread
[119]. After uptake in the body of the next individual, the
particle is exposed to increasing temperatures which “melt”
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Figure 2: Schematic representation of inﬂuenza virus budding. (a)
Formation of the budozone, a coalesced raft domain, in the plasma
membrane. HA (blue) and NA (not shown) are targeted to rafts;
M2 (purple) might be positioned at the edge of the budozone. M1
(red) binds to membranes and all the viral proteins including the
viral RNPs (not shown) and clusters the viral components. The
cytoskeleton (cyan) is involved in establishment of the budozone.
(b) Formation of curvature for budding. Interactions involved: M1
acts as a scaﬀold from beneath, the cytoskeleton provides outward
pushing, the line tension at the domain boundary leads to bending,
and the amphiphilic helix of M2 acts as a wedge. See text for details.
t h ev i r a le n v e l o p e .Al i q u i dm e m b r a n ei sr e q u i r e dt oa l l o w
the fusion of virus particles with cellular membranes.
3.4. Membrane Fusion Activity of HA. Membrane fusion is
divided into several stages: lipid-mixing (hemifusion) and
reversible formation of a fusion pore precedes the ﬁnal
merger of viral and cellular membranes. These events can
be measured separately by loading erythrocyte ghosts with
ﬂuorescent dyes, either the membrane with lipid dyes or the
interior with aqueous dyes, and following their transfer into
HA-expressing cells with ﬂuorescence microscopy [6, 120–
122].
To analyze a possible eﬀect of rafts on membrane
fusion, HA without raft-targeting signals was expressed in
eukaryotic cells and the fusion activity was recorded as
syncytium formation (i.e., fused cells with more than one
nucleus)betweenHA-expressingandneighboringcells.Cells
expressing HA with a deleted raft-targeting signal at the10 Advances in Virology
beginning of the TMR were capable to induce both hemi-
fusion and full fusion, but the number of fusion events was
reduced. Virus particles containing non-raft HA were less
infectious and exhibited reduced fusion activity. However,
since these particles contained less HA, it was concluded that
not the fusion activity per se was compromised but that rafts
concentrate HA for eﬃcient fusion activity [98].
Confusing and partly inconsistent data on the eﬀect
of removal of acylation sites on the fusion activity of HA
have been published. It was reported that nonacylated H1-
and H7-subtype HA and HA of inﬂuenza B virus show
restricted fusion pore formation [101, 123, 124] and that
nonpalmitoylated HA of the H2 subtype revealed impaired
syncytium formation [125]. In contrast, HA deacylation
mutants from the same H2 subtype, but also from H3, and
H7 subtypes mediated cell-cell fusion [126–128]. Likewise,
unperturbed transfer of aqueous dyes into HA-expressing
cells was observed for avian H7-subtype HA in other studies
[129]andalsoforhumanH3-subtypeHA[100].However,in
all cases where an eﬀect of acylation on the membrane fusion
activity of HA was reported, a late event in this process,
namely, the opening, ﬂickering, and/or dilation of the fusion
pore was aﬀected.
Membranefusionisbelievedtoproceedviaafusionstalk,
where lipids with a certain structure connect the viral enve-
lope with the cellular membrane such that lipid exchange
occurs between the outer leaﬂets of both membranes [120].
It is conceivable that HA-bound fatty acids might perturb
the organization of the membrane lipids at this stage of the
fusion process, which would then accelerate opening and/or
dilation of the fusion pore and allow membrane fusion to
proceed to completion. Alternatively, HA-bound fatty acids
mightnotworkdirectlyduringfusion,butattractcholesterol
to the viral envelope, which could serve a speciﬁc function
during membrane fusion.
A direct role of cholesterol during membrane fusion
was addressed in several studies. Extraction of cholesterol
from virus particles reduced their infectivity, most likely
due to an inhibition of membrane fusion [130]. In a
more comprehensive analysis, HA-expressing insect cells,
which naturally contain low cholesterol levels, were loaded
with cholesterol and fusion with erythrocytes (labeled with
ﬂuorescent dyes) was measured. Cholesterol enhanced the
rate of lipid mixing (a marker for hemifusion) and the
amount and extent of aqueous dye transfer (a marker for
fusion pore expansion). It was concluded that cholesterol
acts both at an early stage of fusion, that is, prior to
fusion pore opening, and at an late stage during fusion
pore expansion [131]. In principle, the fusion-promoting
eﬀect of cholesterol might be due to three, not mutually
exclusive, modes of action. First, cholesterol might bind
to the transmembrane region of HA thereby directing the
conformational changes required for fusion. Secondly, the
negative membrane curvature spontaneously induced by the
sterol might promote the local bilayer bending that takes
place during membrane fusion. Finally, cholesterol might
increasethemobilityofHAinthemembranethatisrequired
for fusion pore expansion by increasing the fraction of lipids
in the ﬂuid state.
The confusing and partly inconsistent variety of pub-
lished data on the eﬀect of acylation site removal on
the fusion activity of HA suggests that the methods used
are not ideally suited for this purpose. It is questionable
whether syncytium formation and fusion of HA-expressing
cells with erythrocytes accurately reﬂect entry of inﬂuenza
virus into target cells. Furthermore, these methods are
only semiquantitative and kinetic measurements are barely
possible. In addition, the fusion activity of HA depends on
its density on the cell surface [132], which can hardly be
measured accurately and cannot be controlled in conven-
tional expression systems. It would be helpful to establish an
experimental fusion system composed of closely controlled
amounts of puriﬁed HA (with and without raft-targeting
signals) reconstituted into lipid vesicles with the authentic
composition of the viral envelope and ﬂuorescently labeled
liposomes as the target membrane to quantitatively analyze
the contribution of HA-linked fatty acids to fusion pore
formation and its widening.
4. Conclusion
In summary, HA might pass through a functional “raft
cycle” during replication of inﬂuenza virus. In the Golgi,
HA associates with membrane rafts, which might form
vesicles to facilitate transport of entrapped proteins to the
apical membrane. At the plasma membrane, HA induces the
formation of the viral budozone, a membrane nanodomain
whereassemblyofviralcomponentsandexclusionofcellular
proteins occur. Upon assembly of all virus components,
HA might cause bending of the membrane and M2, which
is supposedly attracted to the edge of the viral budozone,
might mediate pinching oﬀ of virus particles. Budding
of virus particles through rafts equips the particle with
an appropriate lipid mixture that protects particles from
environmental damage and, in the case of cholesterol, might
promote membrane fusion upon virus entry. Thus, rafts
are functionally indispensable for the replication cycle of
inﬂuenza virus and hence perhaps a possible target for anti-
inﬂuenza drugs to be developed.
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